Dipal Doshi - CEO, Director at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
TRDA on Nasdaq
All Insider Reports
All Insider Reports

Dipal Doshi - trading volume in the past year for Entrada Therapeutics, Inc.

Holdings reported by Dipal Doshi for Entrada Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 326K $4.93M $15.13 Sep 5, 2024 Direct
Stock Option (Right to Buy) 159K Mar 1, 2024 Direct Common Stock

Transactions reported by Dipal Doshi for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.